| A novel genome-wide in vivo screen for metastatic suppressors in human colon cancer identifies the positive WNT-TCF pathway modulators TMED3 and SOX12 | EMBO molecular medicine |  | | 2014 | 757 | 396 |
|
| The river blindness drug Ivermectin and related macrocyclic lactones inhibit WNT-TCF pathway responses in human cancer | EMBO molecular medicine |  | | 2014 | 727 | 5 |
|
| BMP signaling promotes the growth of primary human colon carcinomas in vivo | Journal of Molecular Cell Biology | | | 2010 | 651 | 0 |
|
